Dr. Jeffrey Trent is President and Scientific Director of the Translational Genomics Research Institute or TGen.

TGen’s mission is to make and translate genomic discoveries into advances in human health. To accomplish this, TGen is assembling a large team of laboratory scientists, computer experts, biomedical engineers and clinical partners who will take the knowledge gained from the Human Genome Project and create practical discoveries that will ultimately help diagnose and treat many diseases.

The joining of science and medicine in this fashion has created a new research vision — a bench-to-patient bedside perspective that is changing how we look at illness.

Prior to forming TGen, Dr. Trent served for ten years at the worlds largest biomedical research institute – the National Institutes of Health in Bethesda, Maryland. There, he founded and directed the laboratory division of the federal agency in charge of coordinating and finalizing the Human Genome Project.

Before his tenure at the NIH, Dr. Trent held an endowed Professorship and the University of Michigan and directed a division of the University of Michigan Comprehensive Cancer Center. Before that, he held similar positions at the Arizona Cancer Center in Tucson.

Dr. Trent has dedicated his career to fighting cancer. His research career has provided important insights into the genetic basis of cancer and has led to improved diagnosis and treatments that are more effective for those battling breast cancer, melanoma, and other forms of this debilitating disease.

He is the author of over 300 manuscripts in the scientific literature, has received numerous honors and awards, and sits on the editorial boards of a dozen scientific publications.